Cystitis
Therapeutic area
Nephrology
Rare disease
No
- Definition
- Inflammation of the urinary bladder.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Cystitis
- Therapeutic area
- Nephrology
- cystitis
- bladder infection
- inflammation of urinary bladder
- urinary bladder inflammation
- Disease mechanisms
- Inflammatory
- All therapeutic areas
- Nephrology
- Severity
- Mild
- MONDO ID
- MONDO:0006032
- Parent condition
- MONDO:0006026
Related records
Broader conditions (7)
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Human disease
- Inflammatory disease
- Urinary bladder disorder
- Urinary system disorder
Narrower conditions (17)
- Acalculous cholecystitis
- Acute cystitis
- Acute gonococcal cystitis
- Chronic cystitis
- Cystitis cystica
- Diphtheritic cystitis
- Emphysematous cholecystitis
- Eosinophilic cryptitis
- Glandular cystitis
- Gonococcal cystitis
- Hemorrhagic cystitis
- Interstitial cystitis
- Prostatocystitis
- Pyelocystitis
- Radiation cystitis
- Trichomonas cystitis
- Trigonitis
Trials (60)
- A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis.
- A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China
- A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain
- A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections
- Bacterial Composition and Recurrent Cystitis in Postmenopausal Women After Treatment With Lactobacilli.
- Bearberry in the Treatment of Cystitis
- Bladder Morphology Using 2 Different Catheter Designs
- Chronic Indwelling Foley and Catheter Associated Trauma (CIF-CAT) Study
- Cidofovir Instillation in Hematopoietic Stem Cell Transplant (HSCT) Recipients With Hemorrhagic Cystitis
- Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis
- Colipral® (Probiotic Strain Escherichia Coli 5C (ECP24®)) for Prevention of Recurrent Cystitis in Menopausal Women
- Comparative Effect of 3 Different Cranberry Extracts on Cystitis Related Urinary Comfort in Women
- Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI)
- Computer-Assisted Treatment of Urinary Tract Infection in Emergency Departments and Community Health Centers
- Cranberry-lingonberry Juice Started During Acute Infection in Prevention of Urinary Tract Infections in Children
- D Mannose in Recurrent Urinary Tract Infections
- Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract Infections
- Dispensing of Antibiotics in Pharmacies for Cystitis According to a Delegation Protocol, Impact of a Decision Support Tool. PHARIBO: PHarmacy and Resolved Antibiotherapy for Urinary Tract Infections
- Effect of Cranberry Extract on the Urinary System
- Effects of Ketamine on Human Bladders and Its Possible Mechanisms
Approved drugs (4)
- Ciprofloxacin
- Ciprofloxacin hydrochloride
- Dimethyl sulfoxide
- Nitrofurantoin
Drugs in development (9)
- Amoxicillin Phase 3
- Clavulanic acid Phase 3
- Eptacog alfa (activated) Phase 2
- Norfloxacin Phase 3
- Omadacycline Phase 2
- Oxygen Phase 2
- Pentosan polysulfate sodium Phase 2
- Probenecid Phase 3
- Sulopenem etzadroxil Phase 3
Other linked drugs (9)
- Alcohol
- Avibactam sodium
- Ceftazidime
- Ceftolozane sulfate
- Piperacillin
- Piperacillin sodium
- Sitafloxacin
- Sulfacytine
- Tazobactam